{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6190321",
  "DateCompleted": {
    "Year": "1983",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0044-0086",
      "JournalIssue": {
        "Volume": "55",
        "Issue": "5-6",
        "PubDate": {
          "Year": "1982",
          "Season": "Sep-Dec"
        }
      },
      "Title": "The Yale journal of biology and medicine",
      "ISOAbbreviation": "Yale J Biol Med"
    },
    "ArticleTitle": "A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.",
    "Pagination": {
      "StartPage": "529",
      "EndPage": "531",
      "MedlinePgn": "529-31"
    },
    "Abstract": {
      "AbstractText": [
        "Bleomycin is an effective drug used in the therapy of many malignant diseases. Such toxicities as fever, chills, and pulmonary fibrosis are well known to occur following administration of this drug. A rare fatal hyperpyrexial response has also been noted with this agent. We describe a case of fatal hyperthermia after an injection of bleomycin. Unlike earlier reported cases, our patient developed her reaction following prior uneventful therapy with bleomycin rather than as a response to initial treatment. Factors that may be related to the hyperpyrexial response to bleomycin are discussed and the relevant literature reviewed."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rosenfelt",
        "ForeName": "F",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Palmer",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Weinstein",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rosenbloom",
        "ForeName": "B",
        "Initials": "B"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Yale J Biol Med",
    "NlmUniqueID": "0417414",
    "ISSNLinking": "0044-0086"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "11056-06-7",
      "NameOfSubstance": "Bleomycin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Bleomycin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "chemically induced",
        "complications"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Lymphoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    }
  ]
}